DGX - Quest Diagnostics, Inc.
This page shows which of the focused investors we track hold DGX and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2023 it was held by 6 managers with an aggregate reported value of $292.11M, which is 0.03% of the combined portfolio.
As of Q2 2023, 6 tracked institutional managers held DGX (Quest Diagnostics, Inc.) with an aggregate reported value of $292.11M — 0.03% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades DGX — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2023
- Ticker
- DGX
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Christopher Davis - Davis Advisors | 1.30% | Reduce -0.3% | 1,513,888 | $212.79M |
| 2 | Sarah Ketterer - Causeway Capital Management | 1.14% | New | 308,493 | $43.36M |
| 3 | Steven Check - Check Capital Management | 2.10% | Reduce -2.6% | 178,086 | $25.03M |
| 4 | Robert Olstein - Olstein Capital Management | 1.50% | Add +20.0% | 66,000 | $9.28M |
| 5 | Lee Ainslie - Maverick Capital | 0.02% | Add +45.2% | 8,046 | $1.13M |
| 6 | First Eagle - First Eagle Investment Management | 0.00% | - | 3,671 | $516K |
Loading holder history for DGX…